American Pharmaceutical Security Act

The American Pharmaceutical Security Act would require the Administrator of the Centers for Medicare & Medicaid Services to submit a report to Congress within one year of enactment on how coverage and reimbursement authorities could be used to protect U.S. and allied markets for active pharmaceutical ingredients and key starting materials, reduce dependence on foreign adversaries, and support domestic manufacturing. The report would include recommendations for price floor commitments to shield domestic producers from unfair foreign practices and prioritize domestically made ingredients when available, while also identifying data gaps in tracking the origin and ownership of these materials.…

AI summary · The lawmakers haven’t published an official summary of this bill yet, so 52 wrote this one from the bill’s text.